AKYA - Akoya Biosciences, Inc.


1.31
0.010   0.763%

Share volume: 85,915
Last Updated: 04-28-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.04%

PREVIOUS CLOSE
CHG
CHG%

$1.30
0.01
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
25%
Profitability 0%
Dept financing 20%
Liquidity 65%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
3.15%
1 Month
-5.76%
3 Months
-56.33%
6 Months
-54.04%
1 Year
-66.06%
2 Year
-81.26%
Key data
Stock price
$1.31
P/E Ratio 
0.00
DAY RANGE
$1.28 - $1.38
EPS 
-$1.12
52 WEEK RANGE
$1.01 - $4.65
52 WEEK CHANGE
-$65.71
MARKET CAP 
113.500 M
YIELD 
N/A
SHARES OUTSTANDING 
49.499 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
1.50
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$113,950
AVERAGE 30 VOLUME 
$153,688
Company detail
CEO: Brian McKelligon
Region: US
Website: akoyabio.com
Employees: 90
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Akoya Biosciences provides spatial biology solutions focused on transforming discovery and clinical research. It offers single-cell resolution with spatial context that provides a wealth of information to visualize tissue organization and disease pathology on a molecular level. The company also provides PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition.

Recent news
loading